Latest Manufacturing News

Page 14 of 335
Atomo Diagnostics has signed an MOU with Innovation Scientific to develop a fourth-generation HIV rapid test using its Galileo cassette. The project could add a new product to Atomo’s pipeline, but regulatory approval, clinical work and definitive commercial agreements remain outstanding.
Ada Torres
Ada Torres
29 Oct 2026
Adisyn has identified graphene at all 12 sampled locations on a full 200mm wafer, moving its low-temperature deposition platform beyond 1cm² laboratory coupons. The ASX-listed technology company ended September with A$14.4 million in cash and no debt, but commercial qualification remains ahead.
Sophie Babbage
Sophie Babbage
29 Oct 2026
AnteoTech reported a quarter of technical milestones and commercial discussions across its battery and life sciences businesses, including new agreements with Xerabrid and Airspeeder. The company ended September with about A$11 million in cash, although an inconsistency in the Appendix 4C reconciliation needs clarification.
Victor Sage
Victor Sage
29 Oct 2026
Magontec’s nine-month revenue rose 28.9% to A$59.4 million as stronger electronic anode sales and a recovery in Metals lifted gross profit to A$12.8 million. The turnaround is generating cash before working-capital movements, but Chinese demand, European automotive weakness and near-term debt maturities remain live risks.
Victor Sage
Victor Sage
29 Oct 2026
EAU Lithium has deepened its technical relationship with Vulcan Energy Resources while the licensed VULSORB technology moves into commercial-scale manufacturing in Germany. The company ended September with A$2.621 million in cash, but its Bolivia strategy remains subject to negotiations and approvals.
Maxwell Dee
Maxwell Dee
29 Oct 2026
INOVIQ will restart its EXO-OC ovarian cancer program through a staged optimisation and verification process after an independent review found sample collection and handling were the main sources of variability. The company is targeting US laboratory-developed test readiness in the first half of 2028, while a leadership change adds another moving part.
Ada Torres
Ada Torres
29 Oct 2026
RocketDNA’s unaudited Q3 FY26 revenue rose 31% year-on-year to A$2.46 million, while xBot recurring revenue exceeded half of group revenue for the first time. The shift comes alongside expanding deployments, a A$2.23 million placement and continued cash investment in the platform.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Li-S Energy has delivered its lithium-sulfur Power Cells to a US Army research centre and completed a near two-hour endurance flight with its Pegasus drone. The milestones advance its defence and aerospace commercialisation pipeline, but neither has yet produced a procurement order or confirmed revenue.
Victor Sage
Victor Sage
29 Oct 2026
Andromeda Metals has lifted independently verified high-purity alumina output to 99.9989% at its continuous pilot plant and sent its first commercial sample to a potential Japanese customer. The result strengthens the technical case for its HPA project, but customer qualification and commercial-scale production remain ahead.
Victor Sage
Victor Sage
29 Oct 2026
Dimerix has more than doubled its cash balance after an Everest Medicines licensing payment and a drawdown from a secured funding facility. The ASX-listed biotech is also advancing its fully recruited Phase 3 trial while preparing a second kidney drug for Phase 2 testing.
Ada Torres
Ada Torres
29 Oct 2026
MyEco Group’s headline Q1 FY27 sales fell 7.8% to A$3.4 million, but the comparison was distorted by a large Ballarat council order last year. Excluding that one-off, sales rose 23.6%, while negative operating cash flow left the company with 2.3 quarters of funding before its post-quarter capital raising.
Victor Sage
Victor Sage
29 Oct 2026
Titomic has strengthened its balance sheet with A$16.5 million in new equity and approval for a further US$10.3 million EXIM loan, while reporting more than A$11.8 million in orders since September. The progress comes with a sharper funding test: quarter-end cash was A$18.1 million after a A$10.4 million operating outflow, and the EXIM facility remains undrawn.
Victor Sage
Victor Sage
29 Oct 2026

Browse the archive

Full archive